AMGN vs ARGX stock comparison
Amgen vs. Argenx · data as of November 13, 2026
Amgen (AMGN) has a market value of about $251.9B, Argenx (ARGX) about $59.6B. Over their latest twelve months Amgen had revenue of $38.9B and Argenx $5.8B.
Both score 2.4 out of 5 on our five checks.
By area, the stronger company is Argenx on future growth; Amgen on track record; Argenx on financial health; Amgen on shareholder returns.
Amgen is cheaper on earnings (P/E 27.0 vs. 33.2), while Argenx grew revenue faster over five years (130.8% vs. 7.6% a year).
Amgen leads on 13 of the compared lines and Argenx on 8.
Side by side
| AMGN | ARGX | |
|---|---|---|
| Size and price | ||
| Market cap | $251.9B | $59.6B |
| Share price | $465.67 | $960.04 |
| Score | ||
| Overall score (of 5) | 2.4 | 2.4 |
| Value | 0 | 0 |
| Future growth | 3 | 4 |
| Track record | 3 | 2 |
| Financial health | 2 | 5 |
| Shareholder returns | 4 | 1 |
| Valuation | ||
| P/E (TTM) | 27.0 | 33.2 |
| Forward P/E | 19.5 | 31.5 |
| Price / free cash flow | 26.3 | 193.0 |
| Price / sales | 6.5 | 10.2 |
| EV / EBITDA | 17.1 | 28.6 |
| PEG | 9.18 | — |
| DCF value vs. price | −26% | −72% |
| Business | ||
| Revenue | $38.9B | $5.8B |
| Net income | $9.4B | $1.9B |
| Free cash flow | $9.6B | $309M |
| Net margin | 24.1% | 32.2% |
| Gross margin (5-yr avg.) | 69.9% | 90.8% |
| ROIC (5-yr avg.) | 13.5% | -7.0% |
| Growth | ||
| Revenue growth (1 yr) | 10.0% | 88.6% |
| Revenue growth (5 yrs, per year) | 7.6% | 130.8% |
| EPS growth (5 yrs, per year) | 2.9% | — |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$40.8B | $5.1B |
| Dividend yield | 2.16% | None |
| Shareholder yield | 2.2% | 0.0% |
| Analysts | ||
| Upside to average target | −7% | +19% |
| Consensus rating | Hold | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: AMGN TTM to September 30, 2026, ARGX TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Amgen or Argenx?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Amgen scores 2.4 out of 5 and Argenx 2.4; the table shows where each one is stronger.
Is Amgen cheaper than Argenx?
On trailing earnings, Amgen trades at a P/E of 27.0 and Argenx at 33.2, so Amgen is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Amgen or Argenx?
Over five years Argenx grew revenue about 130.8% a year and Amgen about 7.6% a year.
Which pays a higher dividend?
Amgen yields 2.16% and Argenx nothing (no dividend).
Full Amgen analysis → Full Argenx analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.